LauraKayeAguilarMDPhD
Pediatric Hematology & Oncology • Newton, MAChief Medical Officer, Diakonos Oncology
Dr. Aguilar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
440 Lexington St
#450
Newton, MA 02466
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1997 - 1999- Baylor College of Medicine (Houston)Residency, Pediatrics, 1994 - 1996
- Baylor College of MedicineClass of 1994
Certifications & Licensure
MA State Medical License 2001 - 2025
TX State Medical License 1995 - 2005
Publications & Presentations
PubMed
- 28 citationsNeoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.Jarrod D. Predina, Brendan F. Judy, Louis A. Aliperti, Zvi G. Fridlender, Aaron Blouin
Cancer Gene Therapy. 2011-12-01 - 21 citationsPhase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.Charu Aggarwal, Andrew R. Haas, Susan Metzger, Laura K. Aguilar, Estuardo Aguilar-Cordova
Molecular Therapy. 2018-05-02 - 123 citationsPhase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.Lee A. Wheeler, Andrea G. Manzanera, Susan Bell, Robert Cavaliere, John M. McGregor
Neuro-Oncology. 2015-11-01
Press Mentions
Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. As Chief Medical OfficerNovember 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
